LITTLE ROCK, AR--(Marketwire - February 12, 2010) -
Highlighted Links |
Medical Video |
Kelyniam Home |
StockProfile.com provides the investing public with a free unique information portal for investors who like to conduct their own research and make their own investment decisions. The platform allows users to review and investigate dynamic publicly traded companies in a user-friendly environment.
Kelyniam is pleased to team up with StockProfile.com in helping inform independent investors who search out new growth companies to invest in. The profile is listed at www.StockProfile.com and can be viewed by searching under the stock symbol KLYG.
Mr. James Ketner, Kelyniam's President and CEO, stated: "We are extremely excited to be chosen by StockProfile.com and added to their impressive roster of exciting growth companies. Kelyniam will use this opportunity to raise awareness with the investing public and continue to explore additional marketing strategies. Joining the StockProfile.com platform is another important step that Kelyniam is taking to ensure that its shareholders and the investment community have continued access to information about our latest announcements, products and services."
Please see Kelyniam's latest video at www.kelyniam.com/medicalvideo.asp for more information about Kelyniam's medical products.
Please visit our website at www.kelyniam.com for more information.
More information about Kelyniam Global, Incorporated:
Kelyniam Global, Inc. is a balanced vertically-integrated company that services a vast array of clients across numerous fields and industries encompassing, but not limited to, medical, automotive, aerospace, jewelry, nautical and consumer products. The company specializes in the use of CADCAM technology with recent developments in the production of high precision replication of artificial bone implants for medical applications.
Safe Harbor Statement
The information in this release, other than historical information, may be
considered forward-looking statements within the provisions of the Private
Securities Litigation Reform Act of 1995. Projections and other
forward-looking statements and management expectations regarding future
events and/or financial performance of the Company -- although given in
good faith -- are inherently uncertain and actual events and/or results may
differ materially.